In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia (Q40716128)
scientific article published on July 2002
Language:
(P31) (Q13442814)
(P50) (Q373427)
(Q50761099)
(Q56447633)
(P304) 729-737
(P407) (Q1860)
(P433) 7
(P478) 30
(P577) Monday, July 1, 2002
(P921) (Q7739)
(Q177094)
(P1433) (Q5421109)
(P1476) "In vitro studies of the combination of imatinib mesylate (Gleevec) and arsenic trioxide (Trisenox) in chronic myelogenous leukemia" (language: en)
(P2093) Kara Johnson
(P2860) (Q33686190)
(Q29547900)
(Q33336718)
(Q43899710)
(Q43977683)
(Q29618788)
(Q43744914)
(Q32118812)
(Q43551001)
(Q34237621)
(Q43614308)
(Q52832799)
(Q25939005)
(Q25938984)
(Q34515285)
(Q43684724)
(Q40718259)
(Q41450560)
(Q72732565)
(Q42539762)
(Q43627756)
(Q41031117)
other details
description scientific article published on July 2002

External Links